strontium(2+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases vertebral fracture incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×2“A 37% reduction in vertebral fractures (RR 0.63, 95% CI 0.56, 0.71) and a 14% reduction in non-vertebral fractures (RR 0.86, 95% CI 0.75, 0.98) were demonstrated over three years with 2 g of strontium ranelate daily in a treatment population.”
Quoted verbatim from Strontium ranelate for preventing and treating postmenopausal osteoporosis.. - Study
- meta-analysis
- Dose
- strontium ranelate 2 g daily
- Population
- Postmenopausal women with osteoporosis (treatment population: prevalent vertebral fractures and/or lumbar spine BMD T score below -2.5 SD); pooled RCTs of strontium ranelate versus placebo; 2 g daily dose stratum, three years
Effect 0.63 risk ratio, 95% CI 0.56 to 0.71
Strontium ranelate for preventing and treating postmenopausal osteoporosis.2006PMID:17054253Permalink
Keep reading
- Everything the graph holds on strontium(2+)
- Every compound studied against Vertebral fracture incidence
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5N0YH58BE85B00X0NPWM5A5